Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Entrada Therapeutics Inc (TRDA)

Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 473,176
  • Shares Outstanding, K 33,678
  • Annual Sales, $ 129,010 K
  • Annual Income, $ -6,680 K
  • 60-Month Beta -0.38
  • Price/Sales 3.62
  • Price/Cash Flow N/A
  • Price/Book 1.86
Trade TRDA with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.33
  • Number of Estimates 3
  • High Estimate 0.05
  • Low Estimate -0.61
  • Prior Year -0.78
  • Growth Rate Est. (year over year) +57.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.81 +19.75%
on 04/19/24
14.24 -0.70%
on 05/08/24
+0.87 (+6.51%)
since 04/09/24
3-Month
11.35 +24.63%
on 03/13/24
15.56 -9.12%
on 02/12/24
-0.98 (-6.51%)
since 02/09/24
52-Week
10.62 +33.19%
on 05/31/23
18.44 -23.29%
on 07/18/23
+1.96 (+16.04%)
since 05/09/23

Most Recent Stories

More News
Vertex Pharmaceuticals Hits Record High on Strong Q1 Earnings

Vertex Pharmaceuticals hits record high on strong earnings, FDA approval for cystic fibrosis medication for infants. Analysts recently boosted price targets.

VRTX : 417.70 (-0.27%)
CRSP : 52.17 (-2.10%)
TRDA : 14.12 (+0.50%)
MRNA : 124.15 (+1.85%)
GILD : 64.71 (-0.32%)
AMGN : 312.03 (+1.54%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Entrada Therapeutics, Inc. ("Entrada" or the "Company") (NASDAQ: TRDA). Such...

TRDA : 14.12 (+0.50%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Entrada Therapeutics, Inc. ("Entrada" or the "Company") (NASDAQ: TRDA). Such...

TRDA : 14.12 (+0.50%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Entrada Therapeutics, Inc. ("Entrada" or the "Company") (NASDAQ: TRDA). Such...

TRDA : 14.12 (+0.50%)
Biotech Stock Roundup: MDGL Surges on NASH Data, TRDA, RCUS Down on Updates & More

Pipeline updates from Madrigal (MDGL) and Entrada (TRDA) are the key highlights from the biotech sector during the past week.

GILD : 64.71 (-0.32%)
BLUE : 1.1650 (+19.54%)
MDGL : 207.26 (-0.37%)
RCUS : 16.64 (+9.04%)
TRDA : 14.12 (+0.50%)
Entrada (TRDA) Down on Regulatory Update for DMD Candidate

Entrada (TRDA) plunges on clinical hold notice from the FDA regarding its Investigational New Drug Application (IND) for Duchenne muscular dystrophy (DMD) candidate.

GILD : 64.71 (-0.32%)
VRTX : 417.70 (-0.27%)
K : 61.78 (-0.88%)
KALA : 6.79 (-4.10%)
TRDA : 14.12 (+0.50%)
Biotech Stock Roundup: HZNP Surges on AMGN Offer, TRDA Gains on VRTX Deal & More

Acquisitions news from HZNP and AMGN form the key highlights from the biotech sector during the past week.

AMGN : 312.03 (+1.54%)
GILD : 64.71 (-0.32%)
VRTX : 417.70 (-0.27%)
HZNP : 116.30 (+0.04%)
TRDA : 14.12 (+0.50%)
Entrada (TRDA) Surges on Collaboration With Vertex for DMI

Entrada (TRDA) gains from its collaboration deal with Vertex to discover and develop Endosomal Escape Vehicle (EEV) therapeutics for DM1.

BIIB : 220.92 (+0.55%)
GILD : 64.71 (-0.32%)
VRTX : 417.70 (-0.27%)
TRDA : 14.12 (+0.50%)
Vertex and Entrada Therapeutics Establish Collaboration to Discover and Develop Endosomal Escape Vehicle (EEV) Therapeutics for Myotonic Dystrophy Type 1 (DM1)

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced a global collaboration focused on discovering and developing intracellular Endosomal...

VRTX : 417.70 (-0.27%)
TRDA : 14.12 (+0.50%)
Entrada Therapeutics Reports Second Quarter 2022 Financial Results

On track to submit Investigational New Drug application to the U.S. Food and Drug Administration for ENTR-601-44 targeting Duchenne muscular dystrophy in...

TRDA : 14.12 (+0.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Entrada Therapeutics Inc. is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicles(TM) to engage intracellular targets. Entrada Therapeutics Inc. is based in BOSTON.

See More

Key Turning Points

3rd Resistance Point 15.12
2nd Resistance Point 14.68
1st Resistance Point 14.37
Last Price 14.12
1st Support Level 13.61
2nd Support Level 13.17
3rd Support Level 12.86

See More

52-Week High 18.44
Fibonacci 61.8% 15.45
Fibonacci 50% 14.53
Last Price 14.12
Fibonacci 38.2% 13.61
52-Week Low 10.62

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar